6.19
price up icon1.81%   0.11
pre-market  Pre-market:  6.28   0.09   +1.45%
loading
Optimizerx Corp stock is traded at $6.19, with a volume of 437.24K. It is up +1.81% in the last 24 hours and up +17.23% over the past month. OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.
See More
Previous Close:
$6.08
Open:
$6.14
24h Volume:
437.24K
Relative Volume:
0.91
Market Cap:
$116.16M
Revenue:
$107.35M
Net Income/Loss:
$6.84M
P/E Ratio:
17.53
EPS:
0.3532
Net Cash Flow:
$14.64M
1W Performance:
+26.33%
1M Performance:
+17.23%
6M Performance:
-50.16%
1Y Performance:
-52.82%
1-Day Range:
Value
$6.04
$6.50
1-Week Range:
Value
$4.885
$6.50
52-Week Range:
Value
$4.54
$22.25

Optimizerx Corp Stock (OPRX) Company Profile

Name
Name
Optimizerx Corp
Name
Phone
248-651-6558
Name
Address
260 CHARLES STREET, WALTHAM, MI
Name
Employee
105
Name
Twitter
@OpRxTweets
Name
Next Earnings Date
2026-08-06
Name
Latest SEC Filings
Name
OPRX's Discussions on Twitter

Compare OPRX vs VEEV, BTSG, TEM, HQY, HNGE

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
OPRX icon
OPRX
Optimizerx Corp
6.19 107.34M 107.35M 6.84M 14.64M 0.3532
VEEV icon
VEEV
Veeva Systems Inc
192.74 28.83B 3.32B 941.65M 1.64B 5.6161
BTSG icon
BTSG
Brightspring Health Services Inc
69.03 13.69B 13.65B 169.86M 412.12M 1.0758
TEM icon
TEM
Tempus Ai Inc
60.27 10.40B 1.36B -302.91M -219.93M -1.7182
HQY icon
HQY
Healthequity Inc
95.31 7.55B 1.34B 230.70M 440.96M 2.6695
HNGE icon
HNGE
Hinge Health Inc
84.05 6.42B 646.34M -512.40M 202.76M -6.6871

Optimizerx Corp Stock (OPRX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-08-25 Downgrade RBC Capital Mkts Outperform → Sector Perform
Dec-20-24 Initiated Stephens Equal-Weight
Jul-25-24 Resumed B. Riley Securities Buy
Apr-04-24 Initiated JMP Securities Mkt Outperform
Jan-03-24 Initiated Barclays Equal Weight
Feb-02-23 Resumed B. Riley Securities Buy
Nov-01-22 Initiated Stifel Buy
Jul-15-22 Initiated SVB Leerink Outperform
Oct-18-21 Resumed B. Riley Securities Buy
Apr-13-21 Initiated RBC Capital Mkts Outperform
Jan-03-19 Initiated William Blair Outperform
View All

Optimizerx Corp Stock (OPRX) Latest News

pulisher
Jul 01, 2026

OptimizeRx Corp. Hits New 52-Week Low at $4.54 Amid Market Struggles - MarketsMojo

Jul 01, 2026
pulisher
Jun 30, 2026

OptimizeRx stock rises after launching CopayCue product By Investing.com - Investing.com Australia

Jun 30, 2026
pulisher
Jun 30, 2026

OptimizeRx stock rises after launching CopayCue product - Investing.com

Jun 30, 2026
pulisher
Jun 30, 2026

OptimizeRx launches CopayCue for prescription savings - Investing.com

Jun 30, 2026
pulisher
Jun 30, 2026

OptimizeRx launches CopayCue for prescription savings By Investing.com - Investing.com Canada

Jun 30, 2026
pulisher
Jun 30, 2026

OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent - The Manila Times

Jun 30, 2026
pulisher
Jun 30, 2026

OptimizeRx Launches CopayCue to Deliver Brand Savings Offers at the Point of Prescribing - Quiver Quantitative

Jun 30, 2026
pulisher
Jun 30, 2026

OptimizeRx ties copay offers to physician intent at prescribing moment - Stock Titan

Jun 30, 2026
pulisher
Jun 30, 2026

OptimizeRx Corporation (OPRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Jun 30, 2026
pulisher
Jun 29, 2026

Stifel reiterates Buy on OptimizeRX stock, cites AI tool launch By Investing.com - Investing.com South Africa

Jun 29, 2026
pulisher
Jun 29, 2026

OptimizeRx stock rating maintained at Market Outperform by Citizens - Investing.com Nigeria

Jun 29, 2026
pulisher
Jun 28, 2026

OptimizeRx Corporation(NasdaqCM: OPRX) dropped from Russell 2000 Dynamic Index - marketscreener.com

Jun 28, 2026
pulisher
Jun 26, 2026

OptimizeRx Corp (OPRX) Institutional Confidence - TradingKey

Jun 26, 2026
pulisher
Jun 26, 2026

OptimizeRx Announced the Launch of Natural Language Audience Builder - MarTech Cube

Jun 26, 2026
pulisher
Jun 25, 2026

OptimizeRx Launches AI-Powered Natural Language Audience Builder for DSP and Media Planning Platforms - Quiver Quantitative

Jun 25, 2026
pulisher
Jun 25, 2026

OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms - Moomoo

Jun 25, 2026
pulisher
Jun 25, 2026

Citizens reiterates Market Outperform on OptimizeRX stock at forum By Investing.com - Investing.com Australia

Jun 25, 2026
pulisher
Jun 25, 2026

Citizens reiterates Market Outperform on OptimizeRX stock at forum - Investing.com

Jun 25, 2026
pulisher
Jun 23, 2026

OptimizeRx Corp (OPRX) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 23, 2026
pulisher
Jun 23, 2026

OptimizeRx Corp (OPRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 23, 2026
pulisher
Jun 19, 2026

OptimizeRx StockAnalyst expectations and recent price levels on a quiet news day - AD HOC NEWS

Jun 19, 2026
pulisher
Jun 18, 2026

OptimizeRx Corp (OPRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

OptimizeRx Corp (OPRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

OptimizeRx Corp (OPRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 18, 2026
pulisher
Jun 17, 2026

OptimizeRx's Q4 Beat: A Closer Look at the Numbers - Kavout | AI

Jun 17, 2026
pulisher
Jun 17, 2026

OptimizeRx (OPRX) Stock Sees Fair Value Cut As Analysts Reset Growth Expectations - Yahoo Finance

Jun 17, 2026
pulisher
Jun 17, 2026

OptimizeRx Corp (OPRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

OptimizeRx Corp (OPRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

OptimizeRx Corp (OPRX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

OptimizeRx Expands EHR Advertising Reach With New DSP Integration - qz.com

Jun 17, 2026
pulisher
Jun 12, 2026

OptimizeRx (NASDAQ: OPRX) holders add 1M plan shares, reject evergreen - Stock Titan

Jun 12, 2026
pulisher
Jun 11, 2026

OptimizeRx Secures $35 Million Senior Credit Facility to Fuel Growth - citybuzz -

Jun 11, 2026
pulisher
Jun 11, 2026

ContactThe Lethbridge HeraldNews and Sports from around Lethbridge - FinancialContent

Jun 11, 2026
pulisher
Jun 11, 2026

OPRX SEC FilingsOptimizerx Corp 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 11, 2026
pulisher
Jun 11, 2026

OptimizeRx: A Good Business That Has Not Yet Earned Back Investor Trust - Investing.com

Jun 11, 2026
pulisher
Jun 10, 2026

OptimizeRx (OPRX) grants 34,517 restricted stock units to director - Stock Titan

Jun 10, 2026
pulisher
Jun 10, 2026

[Form 4] OptimizeRx Corp Insider Trading Activity - Stock Titan

Jun 10, 2026
pulisher
Jun 10, 2026

OptimizeRx (OPRX) director Gregory Wasson awarded 34,517 restricted stock units - Stock Titan

Jun 10, 2026
pulisher
Jun 10, 2026

OptimizeRx (NASDAQ: OPRX) director receives 34,517 restricted stock units - Stock Titan

Jun 10, 2026
pulisher
Jun 09, 2026

OptimizeRx Corp stock: Q1 earnings beat lifted shares - AD HOC NEWS

Jun 09, 2026
pulisher
Jun 05, 2026

OptimizeRx Corp. Sees Valuation Upgrade Amid Positive Financial Trends and High Institutional Confidence - MarketsMojo

Jun 05, 2026
pulisher
Jun 05, 2026

OptimizeRx parts ways with Theresa Greco; will serve as advisor through June 15, 2027 - TradingView

Jun 05, 2026
pulisher
Jun 05, 2026

OptimizeRx (NASDAQ: OPRX) details CCO exit, $380K salary continuation - Stock Titan

Jun 05, 2026
pulisher
Jun 05, 2026

OptimizeRx Corporation Announces Resignation of Theresa Greco as Chief Commercial Officer Role, Effective June 15, 2026 - marketscreener.com

Jun 05, 2026
pulisher
Jun 04, 2026

OPRX Technical Analysis | Trend, Signals & Chart Patterns | OPTIMIZERX CORP (NASDAQ:OPRX) - ChartMill

Jun 04, 2026
pulisher
Jun 01, 2026

OptimizeRx to Participate in Upcoming Investor Conferences - The Globe and Mail

Jun 01, 2026
pulisher
Jun 01, 2026

Where to meet OptimizeRx: investor 1x1s in Boston and Chicago - Stock Titan

Jun 01, 2026
pulisher
May 29, 2026

OPRX Q1 2026 Earnings: EPS Surges 4017% Above Estimates Amid Strong ExecutionEPS Estimate Trend - The Legal Advocate

May 29, 2026
pulisher
May 28, 2026

OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet? - TradingView

May 28, 2026
pulisher
May 26, 2026

OPRXOptimizeRx Corp Stock Price and Quote - Finviz

May 26, 2026
pulisher
May 25, 2026

OptimizeRx Holds Steady at $4.94 as Traders Await a CatalystFast Moving Stocks - Město Břeclav

May 25, 2026

Optimizerx Corp Stock (OPRX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Optimizerx Corp Stock (OPRX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Stelmakh Edward
Chief Finance & Strat Officer
Dec 19 '25
Sale
13.51
1,388
18,752
126,830
Silvestro Stephen L
Chief Executive Officer
Dec 19 '25
Option Exercise
0.00
6,546
0
195,462
Odence-Ford Marion
Chief Legal & Admin Officer
Dec 19 '25
Option Exercise
0.00
3,928
0
94,526
Besch Doug
Chief Product & Tech Officer
Dec 19 '25
Option Exercise
0.00
1,964
0
71,536
Odence-Ford Marion
Chief Legal & Admin Officer
Oct 03 '25
Option Exercise
0.00
6,649
0
92,550
Silvestro Stephen L
Chief Executive Officer
Oct 03 '25
Option Exercise
0.00
6,649
0
190,536
Silvestro Stephen L
Chief Executive Officer
Oct 03 '25
Sale
18.75
1,620
30,375
188,916
Stelmakh Edward
Chief Finance & Strat Officer
Oct 03 '25
Option Exercise
0.00
16,623
0
127,387
Besch Doug
Chief Product & Tech Officer
Oct 03 '25
Option Exercise
0.00
3,325
0
70,555
Spangler Patrick D
Director
Aug 28 '25
Sale
17.49
11,120
194,489
44,215
$27.36
price up icon 1.79%
$21.86
price up icon 1.25%
$50.07
price up icon 0.11%
WAY WAY
$23.46
price up icon 9.47%
TXG TXG
$39.01
price down icon 0.10%
$84.05
price down icon 1.20%
Cap:     |  Volume (24h):